recent
pandem
highlight
need
rapid
therapeut
develop
infecti
diseas
acceler
process
present
deep
learn
base
gener
model
framework
cogmol
design
drug
candid
specif
given
target
protein
sequenc
high
offtarget
select
augment
gener
framework
silico
screen
process
account
toxic
lower
failur
rate
gener
drug
candid
later
stage
drug
develop
pipelin
appli
framework
three
relev
protein
viru
respons
name
nonstructur
protein
replicas
main
proteas
receptorbind
domain
rbd
protein
dock
target
protein
demonstr
potenti
gener
molecul
ligand
structur
similar
analys
impli
novelti
gener
molecul
respect
train
dataset
well
possibl
biolog
associ
number
gener
molecul
might
relev
therapeut
design
valid
molecul
underway
releas
novel
drug
candid
gener
use
framework
gener
novel
drug
molecul
daunt
task
task
aim
creat
new
molecul
optim
known
molecul
multipl
desir
properti
often
compet
tightli
interact
exampl
optim
drug
molecul
easi
synthes
bind
affin
specif
target
protein
interest
low
bind
affin
target
also
exhibit
high
drug
likeli
qed
make
drug
discoveri
costli
billion
usd
timeconsum
process
decad
low
success
rate
less
tradit
silico
molecul
design
screen
reli
consider
domain
knowledg
physicsbas
simul
heurist
search
algorithm
howev
optim
discret
unstructur
spars
molecular
space
remain
intrins
difficult
challeng
result
lot
interest
develop
autom
machin
learn
techniqu
effici
discov
sizeabl
number
plausibl
divers
novel
candid
molecul
vast
space
molecul
polishchuk
et
al
recent
surg
develop
machin
learn
base
model
candid
drug
screen
novel
molecul
design
simplifi
molecular
input
line
entri
specif
smile
text
string
represent
molecul
popular
choic
repres
molecul
model
wherea
earlier
approach
gener
molecul
involv
recurr
neural
network
rnn
segler
et
al
gupta
et
al
recent
method
employ
gener
framework
variat
autoencod
vae
et
al
blaschk
et
al
kang
cho
lim
et
al
gener
adversari
network
gan
guimara
et
al
recent
increas
interest
molecular
graphbas
gener
method
li
et
al
li
et
al
simonovski
komodaki
samanta
et
al
et
al
kajino
particular
challeng
smilesbas
gener
approach
ensur
gener
string
syntact
valid
smile
grammar
kusner
et
al
dai
et
al
ad
grammar
constraint
smile
string
improv
chemic
valid
gener
molecul
unfortun
approach
also
suffer
sever
shortcom
exampl
model
permutationinvari
node
label
train
quadrat
complex
concern
number
node
gener
semant
valid
graph
challeng
jin
et
al
consid
stateoftheart
architectur
context
repres
molecular
graph
fragment
ring
atom
branch
connect
tree
structur
among
ganbas
approach
de
cao
kipf
introduc
molgan
gan
train
reinforc
learn
rl
gener
molecular
graph
reinforc
learn
rl
method
bayesian
optim
bo
often
employ
top
smilesbas
graphbas
molecul
gener
ensur
valid
molecul
gener
andor
gener
molecul
desir
structur
properti
popova
et
al
olivecrona
et
al
jaqu
et
al
putin
et
al
zhavoronkov
et
al
et
al
bo
et
al
rl
zhou
et
al
zhavoronkov
et
al
incur
high
comput
cost
requir
larg
number
evalu
semisupervis
learn
also
use
condit
gener
lim
et
al
kang
cho
li
et
al
need
label
avail
gener
model
train
order
gener
drug
specif
particular
target
gener
model
exist
work
zhavoronkov
et
al
li
et
al
typic
finetun
subset
molecul
bind
target
approach
requir
model
finetun
singl
target
interest
also
limit
exploratori
capabl
model
term
gener
account
offtarget
select
broader
context
also
becom
nontrivi
set
propos
altern
method
name
control
gener
molecul
cogmol
first
learn
model
captur
vast
molecular
space
use
variat
autoencod
map
known
relationship
protein
sequenc
exist
drug
molecul
train
bind
affin
predictor
posthoc
learn
latent
featur
drug
molecul
protein
sequenc
embed
result
model
handl
candid
molecul
gener
mani
target
protein
sequenc
rather
requir
model
retrain
everi
individu
target
approach
also
allow
perform
control
gener
explicitli
take
offtarget
select
account
addit
control
druglikeli
ad
finetun
control
gener
process
design
molecul
screen
use
multitask
deep
learn
classifi
train
predict
toxic
sever
vitro
clinic
endpoint
hope
account
import
factor
select
toxic
within
ai
framework
help
silico
drug
design
process
faster
agil
less
costli
lead
shorter
discoveri
pipelin
high
success
rate
given
urgenc
ongo
pandem
appli
cogmol
gener
candid
molecul
bind
one
three
relev
target
protein
viru
name
replicas
main
proteas
receptorbind
domain
rbd
protein
act
inhibitor
see
figur
gener
molecul
might
serv
blueprint
creat
drug
potenti
bind
viral
protein
high
target
affin
high
offtarget
select
well
high
druglikeli
depict
figur
targetspecif
drug
design
pipelin
includ
follow
compon
variat
autoencod
vae
first
train
unsupervis
jointli
attribut
regressor
qed
synthet
access
sa
learn
disentangl
latent
space
molecul
smile
represent
attributecondit
sampl
scheme
gener
molecul
desir
attribut
latent
space
silico
screen
gener
molecul
use
sequencelevel
toxic
affin
predictor
first
three
step
constitut
cogmol
last
step
empow
silico
screen
use
mose
benchmark
dataset
polykovskiy
et
al
unsupervis
vae
train
includ
molecul
trainingtestscaffold
test
set
zinc
databas
irwin
shoichet
molecul
filter
molecular
weight
rang
dalton
number
rotat
bond
greater
logp
less
equal
molecul
contain
charg
atom
well
atom
besid
c
n
f
cl
br
h
cycl
longer
atom
remov
molecul
filter
via
medicin
chemistri
filter
mcf
pain
filter
targetspecif
compound
design
use
curat
compoundprotein
bind
data
bindingdb
gilson
et
al
report
deepaffin
karimi
et
al
sinc
object
build
best
bind
affin
regress
model
use
avail
data
also
ad
four
exclud
class
train
data
variat
autoencod
vae
kingma
well
frame
autoencod
probabilist
formal
constrain
express
latent
space
z
sampl
defin
encod
distribut
q
zx
sampl
encod
distribut
constrain
close
simpl
prior
distribut
p
z
consid
case
encod
specifi
diagon
gaussian
distribut
ie
encod
neural
network
produc
log
varianc
log
use
bidirect
gate
recurr
unit
gru
linear
output
layer
encod
decod
gru
rnn
hidden
dimens
intermedi
dropout
layer
dropout
probabl
jointli
train
two
properti
predictor
one
qed
one
sa
parameter
feedforward
network
along
vae
predict
x
latent
embed
x
final
train
vae
qed
sa
predictor
bindingdb
small
molecul
report
perform
final
vae
model
tabl
test
inform
content
vae
latent
space
train
multipl
attribut
qed
logp
sa
predictor
latent
embed
regress
model
hidden
layer
unit
relu
nonlinear
perform
predictor
report
tabl
show
low
rootmeansquareerror
rmse
test
data
three
attribut
predictor
also
train
bind
affin
regress
model
use
data
bindingdb
model
take
represent
target
protein
sequenc
latent
embed
molecul
input
predict
bind
affin
proteinmolecul
pair
use
pretrain
protein
embed
bepler
berger
initi
weight
protein
protein
embed
molecular
embed
concaten
pass
singl
hidden
layer
hidden
unit
relu
nonlinear
best
model
test
rmse
select
use
extens
hyperparamet
tune
tabl
also
train
bind
affin
predictor
use
smile
x
instead
latent
z
embed
input
molecular
represent
yield
rmse
compar
recent
work
karimi
et
al
object
gener
molecul
simultan
satisfi
multipl
often
conflict
object
specif
want
gener
molecul
high
bind
affin
select
target
high
druglikeli
high
offtarget
select
select
particular
target
often
model
later
stage
drug
develop
pipelin
believ
incorpor
select
candid
gener
stage
contribut
reduct
failur
rate
drug
candid
defin
select
excess
bind
affin
molecul
target
interest
averag
bind
affin
random
select
k
target
bosc
et
al
perform
condit
sampl
use
condit
latent
attribut
space
sampl
class
method
describ
da
et
al
short
class
leverag
attribut
classifi
train
posthoc
latent
space
use
reject
sampl
scheme
gener
sampl
desir
attribut
ad
target
bind
affin
offtarget
select
druglikeli
control
gener
candid
molecul
distribut
cogmolgener
molecul
term
bind
affin
offtarget
select
display
figur
result
indic
gener
highaffin
ligand
challeng
figur
main
proteas
ligand
select
figur
show
five
randomli
chosen
sampl
top
gener
molecul
three
target
figur
convent
molecular
toxic
side
effect
test
carri
via
differ
endpoint
experi
vitro
molecular
assay
vivo
anim
test
clinic
trial
howev
experi
costli
timeconsum
thu
silico
earli
screen
tool
use
multitask
deep
neural
network
mtdnn
assess
toxic
molecul
mtdnn
use
predict
toxic
vitro
endpoint
challeng
also
predict
whether
gener
molecul
would
fail
clinic
trial
use
clintox
data
wu
et
al
inform
allow
us
priorit
test
molecul
less
like
harm
speed
process
find
therapeut
continu
expand
model
includ
endpoint
sinc
toxic
substanc
like
exhibit
toxic
across
multipl
endpoint
multitask
model
improv
predict
exploit
correl
differ
endpoint
multitask
model
also
advantag
underli
train
data
scarc
particularli
clinic
set
mtdnn
model
contain
total
four
hidden
layer
two
share
across
endpoint
two
privat
endpoint
use
dropout
srivastava
et
al
probabl
relu
activ
function
layer
except
last
layer
sigmoid
activ
use
morgan
fingerprint
roger
tabl
appendix
although
auc
valu
slightli
wors
exist
work
liu
et
al
see
tabl
precis
thu
true
posit
rate
achiev
mtdnn
much
higher
comparison
also
report
result
random
forest
rf
model
tabl
show
mtdnn
significantli
outperform
rf
model
term
true
posit
rate
recal
score
therefor
mtdnn
model
use
assess
gener
molecul
toxic
molecul
consid
toxic
predict
toxic
endpoint
also
screen
gener
molecul
affin
select
use
xlevel
bind
affin
predictor
tabl
sec
xlevel
affin
predictor
yield
lower
rmse
compar
zlevel
one
figur
bind
pocket
target
calcul
bind
free
energi
molecul
specif
target
averag
standard
deviat
gener
molecul
minimum
bind
free
energi
kcalmol
gener
molecul
fraction
gener
molecul
bind
free
energi
kcalmol
gener
molecul
show
bind
free
energi
kcalmol
least
one
bind
pocket
specif
target
investig
possibl
bind
mode
gener
molecul
target
protein
perform
dock
gener
molecul
potenti
bind
site
figur
predict
use
prankweb
hoksza
jendel
et
al
within
target
structur
use
autodock
vina
trott
olson
tabl
summar
preliminari
result
dock
run
lowest
energi
dock
mode
gener
molecul
show
bind
free
energi
kcalmol
least
one
bind
pocket
dimer
main
proteas
rbd
respect
also
report
averag
minimum
bind
free
energi
well
fraction
gener
molecul
bind
free
energi
kcalmol
pocket
tabl
figur
show
best
gener
molecul
lowest
bind
free
energi
dock
bind
pocket
target
structur
initi
result
impli
potenti
molecul
inhibitor
target
evalu
assess
novelti
gener
molecul
assign
molecul
score
nov
repres
minim
distanc
maxim
similar
regist
determin
similar
deriv
structur
fingerprint
macc
key
durant
et
al
pair
molecul
k
compound
k
p
tanimoto
willett
et
al
coeffici
two
fingerprint
express
similar
note
novelti
mean
molecul
fingerprint
match
exactli
fingerprint
compound
refer
databas
novelti
distribut
gener
molecul
respect
pubchem
kim
et
al
databas
train
set
given
figur
molecular
fingerprint
use
determin
nearest
neighbor
within
gener
molecul
figur
show
exampl
similar
gener
molecul
connect
blue
dot
select
gener
molecul
purpl
allow
manual
evalu
filter
base
molecular
divers
compar
train
databas
size
find
likelihood
gener
molecul
novelti
valu
respect
larger
pubchem
databas
consist
molecul
major
includ
model
train
find
percentag
gener
molecul
novelti
valu
gener
molecul
main
proteas
rbd
respect
match
exactli
exist
smile
string
pubchem
shown
tabl
smile
report
biolog
activ
pubchem
call
investig
exampl
molecul
pubchem
compound
id
cid
label
gen
data
download
known
inhibitor
plasmepsin
famili
protein
potenti
target
antimalari
drug
due
haemoglobindegrad
activ
cid
also
shown
antimalari
activ
chloroquinesensit
plasmodium
falciparum
infect
rbv
hr
given
rbd
protein
bind
angiotensinconvert
receptor
need
viral
entri
host
cell
hoffmann
et
al
rbd
receptor
activ
investig
target
chloroquin
hydroxi
deriv
known
inhibitor
alreadi
consid
promis
drug
liu
et
al
given
chloroquin
also
antimalaria
drug
cid
show
predict
lowest
dock
bind
free
energi
kcalmol
figur
bind
pocket
rbd
tabl
molecul
deserv
investig
context
also
noteworthi
gener
molecul
highest
predict
rbd
dock
bind
free
energi
kcalmol
top
bind
mode
pocket
share
strong
maximum
common
subgraph
similar
cao
et
al
telavancin
approv
pneumonia
drug
shown
figur
result
indic
cogmol
gener
promis
biolog
relev
drug
candid
beyond
train
dataset
figur
maximum
common
subgraph
similar
cogmolgener
molecul
highest
bind
affin
rbd
left
telavancin
right
drug
approv
nosocomi
pneumonia
paper
propos
cogmol
framework
control
gener
molecul
set
desir
attribut
framework
handl
candid
gener
multipl
target
use
train
model
also
allow
explicit
account
offtarget
select
also
develop
method
screen
gener
candid
use
model
predict
vitro
clinic
toxic
dock
target
protein
show
potenti
gener
molecul
ligand
novelti
gener
molecul
investig
respect
molecul
pubchem
expos
novel
drug
candid
three
target
viru
user
interfac
earli
structur
analys
gener
molecul
reveal
possibl
biolog
associ
might
relev
therapeut
design
valid
gener
promis
molecul
underway
paper
updat
result
tabl
show
perform
toxic
predict
use
mtdnn
random
forest
baselin
mtdnn
significantli
outperform
rf
model
term
true
posit
rate
recal
score
incur
small
penalti
roc
auc
precis
tabl
perform
toxic
predict
use
mtdnn
task
clintox
task
cttox
report
metric
roc
auc
accuraci
balanc
accuraci
true
neg
rate
true
posit
rate
precis
recal
score
refer
tabl
comparison
random
forest
mtdnn
achiev
much
better
true
posit
recal
score
slight
penalti
auc
